Loading companies…
NM
N-Power Medicine
United States · Healthtech
N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.
Product and customers
Its prospective external control-arm platform uses trial-grade data from routine care at community oncology sites to create a comparison cohort, helping sponsors evaluate therapies with smaller or faster trials while patients receive treatment close to home. The company reports its NSCLC ProECA program operating across more than 40 sites.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $32M | Innovatus Capital Partners — ParticipantLabcorp Venture Fund — ParticipantMerck Global Health Innovation Fund — Participant |
Investors
Innovatus Capital PartnersJoined Series BLabcorp Venture FundJoined Series BMerck Global Health Innovation FundJoined Series BCoverage
Sep 2, 2026N-Power Medicine · Series BSimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
Blue Health IntelligenceBlue Health Intelligence combines a one-hour health assessment with doctor-led interpretation and a digital plan for preventive care.€3.4M · €3.4 million growth capital